The poly (ADP ribose) polymerase inhibitor niraparib: Management of toxicities.
Moore KN, Mirza MR, Matulonis UA.
Moore KN, et al.
Gynecol Oncol. 2018 Apr;149(1):214-220. doi: 10.1016/j.ygyno.2018.01.011. Epub 2018 Feb 4.
Gynecol Oncol. 2018.
PMID: 29397193
Review.
Hematologic toxicities include thrombocytopenia, anemia, neutropenia and leukopenia; upfront dose modification to 200mg niraparib for patients with baseline weight of 77kg and/or baseline platelets of 150,000K/uL should be considered to avoid significant hematologic toxici …
Hematologic toxicities include thrombocytopenia, anemia, neutropenia and leukopenia; upfront dose modification to 200mg niraparib for patien …